Featured news from NHIVNA
HIV-related news from NAM
New PrEP studies will be a challenge, statisticians warn
Gus Cairns, 2016-01-26 10:50:00
Two statisticians involved in the PROUD
trials of pre-exposure prophylaxis (PrEP) warn that future trials to test new PrEP drugs and
formulations may be extremely difficult to design.
David Dunn of the UK Medical Research Council and David
Glidden of the University of California, San Francisco say that statisticians
will need to choose and analyse their trial population very carefully if they wish to be
able to demonstrate meaningful results.